Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: Synthesis and Immunosuppressive Activity

Jonathan B. Baell, Robert W. Gable, Andrew J. Harvey, Nathan Toovey, Tanja Herzog, Wolfram Hänsel, Heike Wulff

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

The voltage-gated potassium channel Kv1.3 constitutes a promising new target for the treatment of T-cell-mediated autoimmune diseases such as multiple sclerosis. In this study, we report the discovery of two new classes of Kv1.3 blockers based on the naturally occurring compound khellinone, 5-acetyl-4,7-dimethoxy-6-hydroxybenzofuran: (1) khellinone dimers linked via the alkylation of the 6-hydroxy groups and (2) chalcone derivatives of khellinone formed by Claisen-Schmidt condensation of the 5-acetyl group with aryl aldehydes. In particular, the chalcone 3-(4,7-dimethoxy-6-hydroxybenzofuran-5-yl)-1-phenyl-3-oxopropene (16) and several of its derivatives inhibited Kv1.3 with Kd values of 300-800 nM and a Hill coefficient of 2, displayed moderate selectivity over other Kv1-family K+ channels, suppressed T-lymphocyte proliferation at submicromolar concentrations, and showed no signs of acute toxicity in mice. Because of their relatively low molecular weight and lipophilicity and their high affinity to Kv1.3, aryl-substituted khellinone derivatives represent attractive lead compounds for the development of more potent and selective Kv1. 3 blocking immunosuppressants.

Original languageEnglish (US)
Pages (from-to)2326-2336
Number of pages11
JournalJournal of Medicinal Chemistry
Volume47
Issue number9
DOIs
StatePublished - Apr 22 2004

Fingerprint

Voltage-Gated Potassium Channels
Immunosuppressive Agents
Derivatives
Chalcone
T-cells
Lead compounds
T-Lymphocytes
Alkylation
Aldehydes
Dimers
Autoimmune Diseases
Multiple Sclerosis
Toxicity
Condensation
Molecular Weight
Molecular weight
khellinone

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3 : Synthesis and Immunosuppressive Activity. / Baell, Jonathan B.; Gable, Robert W.; Harvey, Andrew J.; Toovey, Nathan; Herzog, Tanja; Hänsel, Wolfram; Wulff, Heike.

In: Journal of Medicinal Chemistry, Vol. 47, No. 9, 22.04.2004, p. 2326-2336.

Research output: Contribution to journalArticle

Baell, Jonathan B. ; Gable, Robert W. ; Harvey, Andrew J. ; Toovey, Nathan ; Herzog, Tanja ; Hänsel, Wolfram ; Wulff, Heike. / Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3 : Synthesis and Immunosuppressive Activity. In: Journal of Medicinal Chemistry. 2004 ; Vol. 47, No. 9. pp. 2326-2336.
@article{b1af37f477564a01bfc022cd2bc1e708,
title = "Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: Synthesis and Immunosuppressive Activity",
abstract = "The voltage-gated potassium channel Kv1.3 constitutes a promising new target for the treatment of T-cell-mediated autoimmune diseases such as multiple sclerosis. In this study, we report the discovery of two new classes of Kv1.3 blockers based on the naturally occurring compound khellinone, 5-acetyl-4,7-dimethoxy-6-hydroxybenzofuran: (1) khellinone dimers linked via the alkylation of the 6-hydroxy groups and (2) chalcone derivatives of khellinone formed by Claisen-Schmidt condensation of the 5-acetyl group with aryl aldehydes. In particular, the chalcone 3-(4,7-dimethoxy-6-hydroxybenzofuran-5-yl)-1-phenyl-3-oxopropene (16) and several of its derivatives inhibited Kv1.3 with Kd values of 300-800 nM and a Hill coefficient of 2, displayed moderate selectivity over other Kv1-family K+ channels, suppressed T-lymphocyte proliferation at submicromolar concentrations, and showed no signs of acute toxicity in mice. Because of their relatively low molecular weight and lipophilicity and their high affinity to Kv1.3, aryl-substituted khellinone derivatives represent attractive lead compounds for the development of more potent and selective Kv1. 3 blocking immunosuppressants.",
author = "Baell, {Jonathan B.} and Gable, {Robert W.} and Harvey, {Andrew J.} and Nathan Toovey and Tanja Herzog and Wolfram H{\"a}nsel and Heike Wulff",
year = "2004",
month = "4",
day = "22",
doi = "10.1021/jm030523s",
language = "English (US)",
volume = "47",
pages = "2326--2336",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3

T2 - Synthesis and Immunosuppressive Activity

AU - Baell, Jonathan B.

AU - Gable, Robert W.

AU - Harvey, Andrew J.

AU - Toovey, Nathan

AU - Herzog, Tanja

AU - Hänsel, Wolfram

AU - Wulff, Heike

PY - 2004/4/22

Y1 - 2004/4/22

N2 - The voltage-gated potassium channel Kv1.3 constitutes a promising new target for the treatment of T-cell-mediated autoimmune diseases such as multiple sclerosis. In this study, we report the discovery of two new classes of Kv1.3 blockers based on the naturally occurring compound khellinone, 5-acetyl-4,7-dimethoxy-6-hydroxybenzofuran: (1) khellinone dimers linked via the alkylation of the 6-hydroxy groups and (2) chalcone derivatives of khellinone formed by Claisen-Schmidt condensation of the 5-acetyl group with aryl aldehydes. In particular, the chalcone 3-(4,7-dimethoxy-6-hydroxybenzofuran-5-yl)-1-phenyl-3-oxopropene (16) and several of its derivatives inhibited Kv1.3 with Kd values of 300-800 nM and a Hill coefficient of 2, displayed moderate selectivity over other Kv1-family K+ channels, suppressed T-lymphocyte proliferation at submicromolar concentrations, and showed no signs of acute toxicity in mice. Because of their relatively low molecular weight and lipophilicity and their high affinity to Kv1.3, aryl-substituted khellinone derivatives represent attractive lead compounds for the development of more potent and selective Kv1. 3 blocking immunosuppressants.

AB - The voltage-gated potassium channel Kv1.3 constitutes a promising new target for the treatment of T-cell-mediated autoimmune diseases such as multiple sclerosis. In this study, we report the discovery of two new classes of Kv1.3 blockers based on the naturally occurring compound khellinone, 5-acetyl-4,7-dimethoxy-6-hydroxybenzofuran: (1) khellinone dimers linked via the alkylation of the 6-hydroxy groups and (2) chalcone derivatives of khellinone formed by Claisen-Schmidt condensation of the 5-acetyl group with aryl aldehydes. In particular, the chalcone 3-(4,7-dimethoxy-6-hydroxybenzofuran-5-yl)-1-phenyl-3-oxopropene (16) and several of its derivatives inhibited Kv1.3 with Kd values of 300-800 nM and a Hill coefficient of 2, displayed moderate selectivity over other Kv1-family K+ channels, suppressed T-lymphocyte proliferation at submicromolar concentrations, and showed no signs of acute toxicity in mice. Because of their relatively low molecular weight and lipophilicity and their high affinity to Kv1.3, aryl-substituted khellinone derivatives represent attractive lead compounds for the development of more potent and selective Kv1. 3 blocking immunosuppressants.

UR - http://www.scopus.com/inward/record.url?scp=1842729411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842729411&partnerID=8YFLogxK

U2 - 10.1021/jm030523s

DO - 10.1021/jm030523s

M3 - Article

C2 - 15084131

AN - SCOPUS:1842729411

VL - 47

SP - 2326

EP - 2336

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 9

ER -